The U.S. Department of Justice has filed charges against the Indian chemical manufacturer Vasudha Pharma Chem Limited (VPC) and three of its executives for purportedly importing precursor chemicals utilized in the illegal production of fentanyl. These charges, revealed on March 20, are part of a broader federal initiative aimed at combating fentanyl trafficking. In New York City, federal agents apprehended two senior officials from VPC: 63-year-old Tanweer Ahmed Mohamed Hussain Parkar, the Chief Global Business Officer, and 48-year-old Venkata Naga Madhusudhan Raju Manthena, the Marketing Director. A third individual, Krishna Vericharla, a 40-year-old Marketing Representative for VPC, is currently evading capture.
Fentanyl, a potent synthetic opioid, has significantly contributed to the ongoing drug crisis in the United States.The indictment alleges that the defendants engaged in a conspiracy to produce and distribute fentanyl precursor chemicals, fully aware that these substances would be illegally imported into the U.S. for fentanyl manufacturing. It is claimed that the company promoted these chemicals through its website, marketing materials, and at international trade exhibitions. Between March and November 2024, undercover U.S. agents reportedly acquired 25 kilograms of fentanyl precursors from VPC. Additionally, negotiations that took place between August and September 2024 involved a transaction for four metric tons of the chemical N-BOC-4P, with half intended for Sinaloa, Mexico, and the other half for the U.S., at a cost of $380,000.Should they be found guilty, the accused individuals could face sentences of up to 10 years in prison, while Vasudha Pharma Chem Limited, headquartered in Hyderabad, may incur fines of up to $500,000 for each count.The investigation into VPC’s alleged involvement in the illegal drug trade is still ongoing.
